As of 2024-12-13, the Relative Valuation of IGEA Pharma NV (IGPH.SW) is 0.06 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 CHF, the upside of IGEA Pharma NV based on Relative Valuation is 4139.4%.
The range of the Relative Valuation is 0.04 - 0.09 CHF.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 27.3x | 19.3x |
| Forward P/E multiples | 24.4x - 33.7x | 30.0x |
| Fair Price | 0.04 - 0.09 | 0.06 |
| Upside | 2620.8% - 5692.4% | 4139.4% |
| Date | P/E |